In this study, we reassessed the value of primary and CNA-type secondary aberrations in adult ALL treated with standard remission induction protocol according to PALG in relation to mutator enzyme AID/RAG1/2 signatures. This evidence concerns the gene AICDA and acute lymphoblastic leukemia.